Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • Clinical Updates
  • Page 47
Muscle Strength as a Key Determinant of Metabolic Risk in Paediatric Obesity: New Evidence from Milan
Posted inClinical Updates news Pediatrics Specialties

Muscle Strength as a Key Determinant of Metabolic Risk in Paediatric Obesity: New Evidence from Milan

Posted by MedXY By MedXY 07/30/2025
Stronger leg muscles are linked to significantly lower risk of metabolic syndrome in children and adolescents with obesity, highlighting the importance of muscular fitness in paediatric metabolic health.
Read More
Evolving Patterns in Antiseizure Drug Use During Pregnancy: Safer Choices and New Uncertainties
Posted inClinical Updates news OB/GYN & Women's Health Specialties

Evolving Patterns in Antiseizure Drug Use During Pregnancy: Safer Choices and New Uncertainties

Posted by MedXY By MedXY 07/30/2025
A decade-long French study reveals declining prenatal exposure to high-risk antiseizure drugs, increased use of safer alternatives, and a notable rise in prescriptions for newer drugs with uncertain safety profiles.
Read More
Digital Self-Management Tools Enhance Asthma Control
Posted inAllergy & Immunology Clinical Updates news Respiratory Specialties

Digital Self-Management Tools Enhance Asthma Control

Posted by MedXY By MedXY 07/30/2025
A randomized trial shows that a smartphone-based asthma self-management program improves symptom control in adults, though its effectiveness is attenuated in African American participants.
Read More
Opioid Prescribing Down, Imaging Steady: Patterns in US ED Management of Low Back Pain, 2016–2022
Posted inClinical Updates news Psychiatry Specialties

Opioid Prescribing Down, Imaging Steady: Patterns in US ED Management of Low Back Pain, 2016–2022

Posted by MedXY By MedXY 07/30/2025
A large national study shows opioid prescribing for ED low back pain fell sharply from 2016 to 2022, while radiograph use remained high and unchanged.
Read More
Rising Threat: Triazole-Resistant Aspergillus fumigatus and the Challenge of Fungal Antimicrobial Resistance
Posted inClinical Updates Infectious Diseases news Specialties

Rising Threat: Triazole-Resistant Aspergillus fumigatus and the Challenge of Fungal Antimicrobial Resistance

Posted by MedXY By MedXY 07/30/2025
A 29-year genomic study reveals increasing genetic diversity and prevalence of triazole-resistant Aspergillus fumigatus, raising concerns for clinical management and highlighting the need for novel diagnostics and antifungal strategies.
Read More
Novel HIV Peptides Identified During Treatment Interruption May Inform Next-Generation Therapeutic Strategies
Posted inClinical Updates HIV/AIDS news Specialties

Novel HIV Peptides Identified During Treatment Interruption May Inform Next-Generation Therapeutic Strategies

Posted by MedXY By MedXY 07/30/2025
Discovery of genetically conserved, mutation-intolerant HIV peptides in rebound virus during analytic treatment interruption highlights new avenues for mRNA vaccine development and functional HIV cure strategies.
Read More
Managing Chronic Kidney Disease-Associated Pruritus: Advances and Clinical Strategies
Posted inClinical Updates Medical News Nephrology Specialties

Managing Chronic Kidney Disease-Associated Pruritus: Advances and Clinical Strategies

Posted by MedXY By MedXY 07/30/2025
CKD-associated pruritus affects up to 85% of dialysis patients and significantly impairs quality of life. Stepwise management, including novel therapies like nemolizumab, is essential for effective symptom control and improved patient outcomes.
Read More
Elevated Colorectal Cancer Risk in Patients with IBD and Primary Sclerosing Cholangitis: Insights from a National Swedish Cohort
Posted inClinical Updates Gastroenterology news Specialties

Elevated Colorectal Cancer Risk in Patients with IBD and Primary Sclerosing Cholangitis: Insights from a National Swedish Cohort

Posted by MedXY By MedXY 07/30/2025
Patients with inflammatory bowel disease (IBD), particularly those with primary sclerosing cholangitis (PSC) or early-onset disease, face a substantially increased risk of colorectal cancer (CRC), emphasizing the need for vigilant surveillance.
Read More
Antibody-Drug Conjugates in Breast Cancer: Efficacy, Toxicity, and Evolving Management Strategies
Posted inClinical Updates news Oncology Specialties

Antibody-Drug Conjugates in Breast Cancer: Efficacy, Toxicity, and Evolving Management Strategies

Posted by MedXY By MedXY 07/30/2025
Antibody-drug conjugates (ADCs) have transformed breast cancer therapy but bring notable toxicity risks. This review examines the clinical evidence, adverse event management, and future directions for optimizing ADC use.
Read More
FDA Expands Skytrofa Approval to Adults with Growth Hormone Deficiency: Clinical and Practice Implications
Posted inClinical Updates news Pediatrics Specialties

FDA Expands Skytrofa Approval to Adults with Growth Hormone Deficiency: Clinical and Practice Implications

Posted by MedXY By MedXY 07/30/2025
Once-weekly lonapegsomatropin (Skytrofa) is now FDA-approved for adult growth hormone deficiency, offering a more convenient alternative to daily injections with demonstrated efficacy and safety.
Read More
Physical Activity Trajectories Before and After Cardiovascular Disease: Insights from the CARDIA Study
Posted inCardiology Clinical Updates Medical News Specialties

Physical Activity Trajectories Before and After Cardiovascular Disease: Insights from the CARDIA Study

Posted by MedXY By MedXY 07/29/2025
Longitudinal data from CARDIA reveal declining physical activity before and after CVD events, with pronounced disparities among Black women, highlighting the need for targeted interventions across the life course.
Read More
Structured Lifestyle Intervention Shows Superior Cognitive Benefits in At-Risk Older Adults: Insights from the US POINTER Trial
Posted inClinical Updates Medical News Neurology

Structured Lifestyle Intervention Shows Superior Cognitive Benefits in At-Risk Older Adults: Insights from the US POINTER Trial

Posted by MedXY By MedXY 07/29/2025
A large US trial shows that intensive, structured lifestyle programs yield greater cognitive improvement in at-risk older adults compared to self-guided approaches, though both are beneficial.
Read More
Subclinical Primary Aldosteronism: A Hidden Driver of Cardiovascular Risk Beyond Blood Pressure
Posted inCardiology Clinical Updates news

Subclinical Primary Aldosteronism: A Hidden Driver of Cardiovascular Risk Beyond Blood Pressure

Posted by MedXY By MedXY 07/29/2025
Emerging evidence links subclinical primary aldosteronism to significantly increased cardiovascular risk, even in normotensive individuals, highlighting the need for refined screening and personalized hypertension management.
Read More
Widespread Misclassification of Myocardial Infarction Subtypes in Administrative Coding: Implications for Practice and Policy
Posted inCardiology Clinical Updates news Specialties

Widespread Misclassification of Myocardial Infarction Subtypes in Administrative Coding: Implications for Practice and Policy

Posted by MedXY By MedXY 07/29/2025
Audit reveals major misclassification in hospital coding for myocardial infarction types, risking flawed epidemiology, reimbursement, and patient care.
Read More
Increasing Sit-to-Stand Transitions Lowers Diastolic Blood Pressure in Sedentary Postmenopausal Women: Evidence from a Randomized Trial
Posted inCardiology Clinical Updates news Specialties

Increasing Sit-to-Stand Transitions Lowers Diastolic Blood Pressure in Sedentary Postmenopausal Women: Evidence from a Randomized Trial

Posted by MedXY By MedXY 07/29/2025
A 12-week randomized trial finds that increasing daily sit-to-stand transitions reduces diastolic blood pressure in sedentary, overweight, or obese postmenopausal women but does not significantly affect glucose regulation.
Read More
JAK Inhibitors and Thromboembolic Risk in Atopic Dermatitis: A Comparative Safety Signal
Posted inClinical Updates Dermatology Specialties

JAK Inhibitors and Thromboembolic Risk in Atopic Dermatitis: A Comparative Safety Signal

Posted by MedXY By MedXY 07/29/2025
A large real-world cohort study finds JAK inhibitors increase risk of venous thromboembolism versus dupilumab and methotrexate in atopic dermatitis, highlighting the need for individualized therapy.
Read More
Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease
Posted inClinical Updates Medical News Neurology Specialties

Lecanemab in Community Practice: Real-World Safety and Efficacy for Early Alzheimer’s Disease

Posted by MedXY By MedXY 07/29/2025
Community-based data suggest lecanemab is safe and effective for early-stage Alzheimer’s, with manageable ARIA rates and infusion reactions, particularly in ApoE4 noncarriers.
Read More
Structured Lifestyle Interventions Deliver Superior Cognitive Benefits over Self-Guided Approaches in At-Risk Older Adults
Posted inClinical Updates Medical News Neurology Specialties

Structured Lifestyle Interventions Deliver Superior Cognitive Benefits over Self-Guided Approaches in At-Risk Older Adults

Posted by MedXY By MedXY 07/29/2025
A large phase 3 trial reveals that structured, multidomain lifestyle interventions significantly improve cognition in older adults at risk for cognitive decline, outperforming self-guided strategies.
Read More
Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice
Posted inClinical Updates Medical News Neurology Specialties

Alzheimer’s Association Releases First Clinical Guidelines for Blood-Based Biomarkers: Implications for Diagnosis and Practice

Posted by MedXY By MedXY 07/29/2025
New Alzheimer’s Association guidelines endorse blood-based biomarkers as diagnostic adjuncts, not standalone tests, emphasizing rigorous clinical evaluation and high test accuracy.
Read More
Synthetic Opioid Overdose Deaths Among Youth Surge 168%: A Five-Year Analysis and Clinical Implications
Posted inClinical Updates Medical News Psychiatry Specialties

Synthetic Opioid Overdose Deaths Among Youth Surge 168%: A Five-Year Analysis and Clinical Implications

Posted by MedXY By MedXY 07/29/2025
Overdose deaths from synthetic opioids alone in U.S. youth aged 15–24 surged 168% between 2018 and 2022, now representing one-third of all youth OD fatalities. Clinical vigilance, harm reduction, and targeted prevention are urgently needed.
Read More

Posts pagination

Previous page 1 … 45 46 47 48 Next page
  • Survival Unaffected by Surgical Complications in Advanced Esophageal Cancer: A JCOG1109 Exploratory Analysis
  • Peritoneal Cancer Risk After Risk-Reducing Salpingo-Oophorectomy: The Impact of BRCA Mutational Status and STIC Lesions
  • One-Hour Plasma Glucose: A Vital Predictor of Cardiometabolic Risk in Women with PCOS
  • The Shift Toward De-escalation: Why Radical Trachelectomy Is Losing Ground in Early-Stage Cervical Cancer
  • Management of Endometrial Polyps: A Synthesis of Modern Diagnostic and Therapeutic Strategies
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular health cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology exercise health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality nutrition obesity older adults oncology Pediatrics Physical Activity precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in